The global gross domestic product (GDP) may decline by $1.67 trillion by 2050 with accelerated antimicrobial resistance (AMR), highlighting the importance of pursuing intervention strategies. Findings from the Center for Global Development study also showed absolute changes in global GDP in 2050 ranging from $269 billion with better treatment of bacterial infections, to nearly $990 billion when a combined, four-part intervention approach is employed, including improved access to vaccines.
This research investigates the economy-wide effects of AMR in humans by considering five AMR-scenarios to understand the potential global and country-level impacts of resistance, and simulates the combined impacts of AMR-induced changes in population, health care costs, labor, hospitality, and tourism in a computable general equilibrium modeling framework.
Any organization or individual working in the field of immunization economics can submit findings, opportunities, calls to action, or other relevant work below to be shared with our community.